Ocular Therapeutix
OCUL
OCUL
213 hedge funds and large institutions have $2.2B invested in Ocular Therapeutix in 2025 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 71 increasing their positions, 58 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more funds holding
Funds holding: 184 → 213 (+29)
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
9.58% more ownership
Funds ownership: 98.58% → 108.15% (+9.6%)
Holders
213
Holding in Top 10
11
Calls
$22M
Puts
$10.7M
Top Buyers
| 1 | +$142M | |
| 2 | +$43.7M | |
| 3 | +$38.1M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$33.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$31.5M |
Top Sellers
| 1 | -$27.6M | |
| 2 | -$15.3M | |
| 3 | -$13.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$10.9M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$9.57M |
